Loading...
Loading...
By Sandra Sánchez-Oldenhage - Tue, 03/03/2026 - 08:30
Latin American family pharma must institutionalize governance and professionalize to scale amid regulatory complexity, writes Sandra Sanchez.
Featured content
Mon, 01/05/2026 - 08:30
Scaling functional medicine in Mexico requires ecosystem models and precision health to fight chronic disease, writes Gustavo Rodríguez.
https://mexicobusiness.news/tag/pharmaceutical-industry
More Health
By MBN Staff - Mon, 03/02/2026 - 13:07
Mexico’s COFEPRIS has unveiled a new regulatory model to spur innovation, curb counterfeit drugs.
By Aura Moreno - Mon, 03/02/2026 - 08:50
Lilly’s oral GLP-1 orforglipron surpassed semaglutide in A1C reduction and weight loss, reshaping the oral cardiometabolic market.
By Aura Moreno - Fri, 02/27/2026 - 11:51
Mexico’s medical device industry plans US$400 million in investments by 2030, in alignment with Plan México and USMCA dynamics.
By Aura Moreno - Thu, 02/26/2026 - 14:41
The FDA’s qualification of hip bone mineral density as a surrogate endpoint is expected to reshape osteoporosis drug development.
By Aura Moreno - Tue, 02/24/2026 - 08:13
Diagnostic delays and uneven access highlight structural gaps in Mexico’s rare disease care and policy framework.
By Oswaldo Bernal - Mon, 02/23/2026 - 08:30
Plan México and AI-driven clinical research leverage 'creative destruction' to transform national health. Oswaldo Bernal explains.
By Hector Salinas - Fri, 02/20/2026 - 06:00
Pharma MLR review shifts from a bottleneck to a strategic lever using AI, automation, and metrics to boost global reuse, writes Héctor Salinas.
By César Marrón - Tue, 02/17/2026 - 07:30
Mexico is shifting to value-based healthcare, prioritizing efficiency, digital ecosystems, and ethical governance for growth, writes Cesar Marrón.
By Aura Moreno - Sun, 02/15/2026 - 17:54
International Condom Day spotlights Mexico’s expanded STI prevention and coordinated public-private health strategy.
